US charges Canadian company with smuggling, money laundering

An indictment filed in the US District Court in Montana charged Canada Drugs and affiliates in the UK and Barbados with smuggling, money laundering and conspiracy. The online pharmacy sold $78 million worth of unapproved, mislabeled and in some cases, counterfeit cancer drugs to doctors in the US over a three-year period. All but one of the 14 companies and individuals named as defendants are located outside of the US and will force prosecutors to undertake the extradition process.